Healthcare/biotech - Bamboo Works - China stock insights for global investors https://thebambooworks.com/category/healthcare-biotech/ China stock insights for global investors Fri, 17 May 2024 02:03:32 +0000 en-GB hourly 1 https://wordpress.org/?v=6.1.1 https://thebambooworks.com/wp-content/uploads/2022/12/cropped-BBW_website_icon_20221228-32x32.png Healthcare/biotech - Bamboo Works - China stock insights for global investors https://thebambooworks.com/category/healthcare-biotech/ 32 32 B&K Corp eyes IPO to keep its slow-developing drugs alive https://thebambooworks.com/bk-corp-seeks-ipo-to-keep-its-slow-developing-drugs-alive/ Thu, 16 May 2024 03:11:05 +0000 https://thebambooworks.com/?p=32055 The company focuses on wound-healing PDGF drugs and its core product, Pro-101-2, isn’t expected to enter Phase 3 clinical trials for at least three more years Key Takeaways: 　 By Molly Wen A recent rally that’s seen Hong Kong stocks charge into rare bull territory is injecting new life into the exchange’s moribund IPO market......

The post B&K Corp eyes IPO to keep its slow-developing drugs alive appeared first on Bamboo Works.

]]> PODCAST: A New EU Probe, and a Used Car IPO https://thebambooworks.com/podcast-a-new-eu-probe-and-a-used-car-ipo/ Tue, 14 May 2024 08:07:44 +0000 https://thebambooworks.com/?p=32000 The EU has launched a new probe after European firms complained of restricted access to China's huge medical equipment procurement market. Is the EU getting more aggressive on China's trade practices? And used car specialist Autostreets applies for a Hong Kong listing, touting a coming boom in Chinese used car sales. Why have Chinese traditionally preferred new cars, and what's changed now, if anything?

The post PODCAST: A New EU Probe, and a Used Car IPO appeared first on Bamboo Works.

]]> Bayzed joins IPO quest as medical rivalry heats up https://thebambooworks.com/bayzed-joins-ipo-quest-as-medical-rivalry-heats-up/ Tue, 07 May 2024 00:15:55 +0000 https://thebambooworks.com/?p=31714 Bayzed Health Group Inc. seeks Hong Kong listingThe cancer treatment specialist is seeking a Hong Kong listing to fund its campaign in the M&A battle for China’s private healthcare market   Key Takeaways: By Li Shin Ta A bout of IPO fever has swept through China’s private healthcare sector, as companies gear up to expand their reach or fight off their rivals in.....

The post Bayzed joins IPO quest as medical rivalry heats up appeared first on Bamboo Works.

]]> China-focused Tigermed staves off biopharma gloom https://thebambooworks.com/china-focused-tigermed-staves-off-biopharma-gloom/ Wed, 01 May 2024 16:57:11 +0000 https://thebambooworks.com/?p=31469 Investors have not been deterred by an earnings slide, wagering that the drugs services company is better placed to weather an industry storm than some biopharma stocks.Investors have not been deterred by an earnings slide, wagering that the drugs services company is better placed to weather an industry storm than some biopharma stocks Key Takeaways: 　 By Molly Wen In China’s chilly biopharma sector, one company has been relatively insulated against fears of a U.S. order freeze. Despite falling profits, drugs.....

The post China-focused Tigermed staves off biopharma gloom appeared first on Bamboo Works.

]]> Sunho Biologics gets green light for downsized IPO https://thebambooworks.com/sunho-biologics-gets-green-light-for-downsized-ipo/ Fri, 26 Apr 2024 03:37:41 +0000 https://thebambooworks.com/?p=31338 The loss-making developer of cancer immunotherapies raised just enough financing last year to cross the valuation threshold for a Hong Kong listing.The loss-making developer of cancer immunotherapies raised just enough financing last year to cross the valuation threshold for a Hong Kong listing Key Takeaways: 　 By Fai Pui The market conditions may be dire, but Chinese drug developer Sunho Biologics Inc. needs the cash. The loss-making biotech has secured the green light for an IPO,.....

The post Sunho Biologics gets green light for downsized IPO appeared first on Bamboo Works.

]]> New Horizon Health launches probe into disputed sales figures https://thebambooworks.com/new-horizon-health-launches-probe-into-disputed-sales-figures/ Thu, 25 Apr 2024 03:17:45 +0000 https://thebambooworks.com/?p=31267 The provider of cancer-screening products issued a positive profit alert in January, but the full earnings report has yet to appear after auditors raised questions about the company’s revenues.The provider of cancer-screening products issued a positive profit alert in January, but the full earnings report has yet to appear after auditors raised questions about the company’s revenues Key Takeaways: 　 By Molly Wen It was a Chinese success story in the health technology sector, feted by the stock market. New Horizon Health Ltd......

The post New Horizon Health launches probe into disputed sales figures appeared first on Bamboo Works.

]]> BenQ files for IPO as business looks stable, but with few growth spots https://thebambooworks.com/benq-hospital-files-for-ipo-as-business-looks-stable-but-with-few-growth-spots/ Mon, 15 Apr 2024 00:11:30 +0000 https://thebambooworks.com/?p=30948 BenQ Hospital has stable business growth but lacks growth bright spotsChina’s biggest private for-profit hospital operator plans to use funds from its planned listing to expand and upgrade its facilities Key Takeaways: 　 By Lau Chi Hang Cancer treatment private hospital operator Concord Healthcare (2453.HK) thought it had just the right medicine for investors when it listed in Hong Kong early this year, boasting an.....

The post BenQ files for IPO as business looks stable, but with few growth spots appeared first on Bamboo Works.

]]> InSilico seeks IPO boost to get AI drugs over the line https://thebambooworks.com/insilico-seeks-ipo-boost-to-get-ai-drugs-over-the-line/ Thu, 11 Apr 2024 04:18:01 +0000 https://thebambooworks.com/?p=30835 The drug developer has raised around $400 million in seven rounds of financing. But after burning through cash, the company needs fresh capital to sustain its work on AI-assisted drugs.The drug developer has raised around $400 million in seven rounds of financing. But after burning through cash, the company needs fresh capital to sustain its work on AI-assisted drugs Key Takeaways: 　 By Molly Wen A Chinese biotech is bidding to cross the next major frontier in medical science: using artificial intelligence to deliver.....

The post InSilico seeks IPO boost to get AI drugs over the line appeared first on Bamboo Works.

]]> ProfoundBio discovers the joys of having a wealthy owner https://thebambooworks.com/profoundbio-discovers-the-joys-of-having-a-wealthy-owner/ Mon, 08 Apr 2024 04:43:19 +0000 https://thebambooworks.com/?p=30703 ProfoundBio to be bougth by GenmabThe company has become the latest in a recent string of China-related innovative drug makers to be purchased by larger foreign buyers Key Takeaways:    By Doug Young After years of trying to go it alone, innovative Chinese drug makers may finally be starting to realize it’s much easier to have a wealthy parent to.....

The post ProfoundBio discovers the joys of having a wealthy owner appeared first on Bamboo Works.

]]> Akeso marks profit milestone with swift rights issue https://thebambooworks.com/akeso-marks-profit-milestone-with-swift-rights-issue/ Thu, 28 Mar 2024 02:21:36 +0000 https://thebambooworks.com/?p=30384 Buoyed by bumper earnings, the biotech has announced a share placement to raise HK$1.17 billion to invest in developing its portfolio of anti-cancer drugs.Buoyed by bumper earnings, the biotech has announced a share placement to raise HK$1.17 billion to invest in developing its portfolio of anti-cancer drugs Key Takeaways: 　 By Molly Wen Chinese drug company Akeso Inc. (9926.HK) has pushed its way into profit in the biopharma industry’s most competitive arena, developing new ways to help the.....

The post Akeso marks profit milestone with swift rights issue appeared first on Bamboo Works.

]]> PODCAST: Japanese Auto Cuts, and a Drugmaker’s Fall https://thebambooworks.com/podcast-japanese-auto-cuts-and-a-drugmakers-fall/ Tue, 26 Mar 2024 09:21:26 +0000 https://thebambooworks.com/?p=30307 By Doug Young & Rene Vanguestaine Nissan and Honda weigh major cuts of up to 30% in their China car production. What’s driving the trend, and is it likely to speed consolidation in the oversupplied industry? And shares of drugmaker CStone fell 40% after it was booted from the Hang Seng Index and China stock.....

The post PODCAST: Japanese Auto Cuts, and a Drugmaker’s Fall appeared first on Bamboo Works.

]]> Slowing revenue growth hurts online drug platform YSB https://thebambooworks.com/slowing-revenue-growth-hurts-online-drug-platform-ysb/ Thu, 21 Mar 2024 03:30:29 +0000 https://thebambooworks.com/?p=30094 This B2B drug distributor posted higher annual revenues and swung to an adjusted profit, but disappointed investors still sent the firm’s stock down 9% on the day after the earnings.The B2B drug distributor posted higher annual revenues and swung to an adjusted profit, but disappointed investors still sent the firm’s stock down 9% on the day after the earnings Key Takeaways: 　 By Molly Wen Drugs-trading platform YSB Inc. (9885.HK) is feeling the pain from a stock sell-off after delivering its first annual results.....

The post Slowing revenue growth hurts online drug platform YSB appeared first on Bamboo Works.

]]>